Session Information
Session Type: ACR Poster Session B
Session Time: 9:00AM-11:00AM
Background/Purpose: Activation of polyclonal CD4+
T cells and B cells is a hallmark of human and murine lupus,
which suggests a global defect in the maintenance of T and B cell
tolerance. Recent studies unveil a central role of T follicular helper (Tfh)
cells that is critical in providing help to B cells in the overproduction of
pathogenic auto-antibodies and tissue damage in lupus. However, how Tfh cells are deregulated in lupus in mice and humans is currently unknown. The E3
ubiquitin ligase Cbl-b plays a crucial role in T cell activation, tolerance
induction, and Th2 cell differentiation. Cbl-b polymorphisms are linked to
human lupus, and furthermore, Cbl-b expression has been shown to be reduced in
human lupus T cells. However, the role of Cbl-b in lupus pathogenesis is still poorly
defined. In this study,
we test the hypothesis that Cbl-b targets Bcl6, the master transcriptional
regulator for Tfh cell development, for ubiquitination and degradation in mice.
Methods: We introduced Cbl-b
deficiency or a point mutation within RING finger domain of Cbl-b, into lpr mice (carrying a mutation in Fas gene) on
a C57BL/6 background
(B6-lpr.Cblb-/- and B6-lpr.CblbC373A, respectively). To test the feasibility of silencing Cblb in human
T cells, peripheral CD4+ T cells isolated from peripheral blood mononuclear
cells (PBMC) of healthy human donors were transfected with siRNA targeting Cbl-b
using liposomal or nucleofection-based methods.
Results: B6-lpr.Cblb-/- and B6-lpr.CblbC373A mice displayed an exacerbated
and severe lupus-like syndrome. This
was
associated
with expanded
Tfh cells, GC B cells, and plasma cells in the lymph
nodes and spleens
and
heightened
anti-dsDNA
titers in the sera. At molecular level, Cbl-b bound to Bcl-6 upon
Tfh differentiation condition in a Bcl-6 tyrosine-phosphorylation dependent
manner. Furthermore, Bcl-6 ubiquitination and
degradation was abrogated in T cells lacking Cbl-b. Consistent with this data,
Tfh from SLE patients express lower levels of Cbl-b compared to those from
healthy donors.
Conclusion: Our results suggest that that Cbl-b may be the E3
ubiquitin ligase that targets Bcl-6 for degradation. Because both B6-lpr
and human lupus T cells express significantly less Cbl-b, deregulated Cbl-b
expression in human and murine lupus may be a driver of heightened Tfh and GC B
cells causing overproduction of pathogenic auto-antibodies.
To cite this abstract in AMA style:
Willis W, Xiao Y, Young NA, Jarjour WN, Zhang J. Regulation of T Follicular Helper Cells in Systemic Lupus Erythematosus By E3 Ubiquitin Ligase Cbl-b [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/regulation-of-t-follicular-helper-cells-in-systemic-lupus-erythematosus-by-e3-ubiquitin-ligase-cbl-b/. Accessed .« Back to 2015 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/regulation-of-t-follicular-helper-cells-in-systemic-lupus-erythematosus-by-e3-ubiquitin-ligase-cbl-b/